.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Accenture
Johnson and Johnson
Federal Trade Commission
Cantor Fitzgerald
Argus Health
Healthtrust
AstraZeneca
Medtronic
Boehringer Ingelheim

Generated: July 24, 2017

DrugPatentWatch Database Preview

Pharm Res Assoc Company Profile

« Back to Dashboard

What is the competitive landscape for PHARM RES ASSOC, and what generic and branded alternatives to PHARM RES ASSOC drugs are available?

PHARM RES ASSOC has eight approved drugs.



Summary for Applicant: Pharm Res Assoc

Patents:0
Tradenames:9
Ingredients:9
NDAs:8
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharm Res Assoc
PHYLLOCONTIN
aminophylline
TABLET, EXTENDED RELEASE;ORAL086760-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Res Assoc
ATHROMBIN-K
warfarin potassium
TABLET;ORAL011771-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Res Assoc
ATHROMBIN
warfarin sodium
TABLET;ORAL011771-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Res Assoc
CERUMENEX
trolamine polypeptide oleate condensate
SOLUTION/DROPS;OTIC011340-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Res Assoc
T-PHYL
theophylline
TABLET, EXTENDED RELEASE;ORAL088253-001Aug 17, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Daiichi Sankyo
McKesson
Argus Health
Healthtrust
Moodys
Dow
Federal Trade Commission
Queensland Health
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot